|Bid||13.95 x 1200|
|Ask||0.00 x 1400|
|Day's Range||13.85 - 14.40|
|52 Week Range||1.88 - 23.42|
|Beta (5Y Monthly)||1.15|
|PE Ratio (TTM)||N/A|
|Earnings Date||Nov 03, 2021 - Nov 08, 2021|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||22.83|
Amyris, Inc., (Nasdaq: AMRS), a leading synthetic biotechnology company active in the Clean Health, Beauty and Wellness markets through its consumer brands and a top supplier of sustainable and natural ingredients, today announced that it will issue its financial results for the third quarter ended September 30, 2021 after the close of the financial markets on Monday, November 8, 2021.
The genomic revolution is upon us and these stocks could be great vehicles for investors who want to take advantage of it.
The Insider Monkey team has completed processing the quarterly 13F filings for the June quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]